The manufacturer Actavis Group PTC EHF has recalled certain batches of ant-fluid retention medication over concerns they may have become contaminated with N-nitrosodiethylamine (NDEA).
Related Article: Pharmacy First gateway changes to help increase payments
Pharmacists should stop dispensing the affected batches, quarantine them and return all remaining stock to the supplier within 48 hours, the Medicines and Healthcare products Regulatory Agency (MHRA) said yesterday (13 February).
The affected batches are:
Related Article: ‘Precautionary’ recall of breast cancer medication batch
Irbesartan 300mg Film-coated tablets PL 30306/0108
| Batch Number |
Expiry Date |
Pack Size |
First Distributed |
| 191018 |
05/2020 |
1 x 28 |
30 Nov 2018 |
| 191118 |
05/2020 |
1 x 28 |
20 Dec 2018 |
Irbesartan / Hydrochlorothiazide 300 / 25mg Film-coated tablets, PL 30306/0267
Related Article: Customer complaint prompts recall of Omeprazole oral solution batch
| Batch Number |
Expiry Date |
Pack Size |
First Distributed |
| 263918 |
06/2020 |
1 x 28 |
21 Nov 2018 |
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.